about
Identification of a human cyclin D1-derived peptide that induces human cytotoxic CD4 T cellsOral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis.DNA vaccination: using the patient's immune system to overcome cancerHMGA proteins as modulators of chromatin structure during transcriptional activation.Enhancement of DNA vaccine efficacy by targeting the xenogeneic human chorionic gonadotropin, survivin and vascular endothelial growth factor receptor 2 combined tumor antigen to the major histocompatibility complex class II pathway.Mechanisms of regression.
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
What's new in the field of cancer vaccines?
@ast
What's new in the field of cancer vaccines?
@en
type
label
What's new in the field of cancer vaccines?
@ast
What's new in the field of cancer vaccines?
@en
prefLabel
What's new in the field of cancer vaccines?
@ast
What's new in the field of cancer vaccines?
@en
P2093
P1476
What's new in the field of cancer vaccines?
@en
P2093
P2888
P304
P356
10.1007/S00018-003-2185-X
P577
2003-07-01T00:00:00Z